There is an inverse association between serum carotenoid levels and adult migraine risk, according to study findings.

Poor quality of sleep is associated with incident motoric cognitive risk syndrome, but not prevalent motor cognitive risk syndrome.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

RNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes.

For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine 181 (p-tau181).

Chronic loneliness is associated with increased risk of stroke after adjustment for depressive symptoms and social isolation.

A sleep-mood intervention improves insomnia symptoms in university students but has little impact on their mental health and quality of life.

The US Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid epidemic.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The global prevalence and rank of nonfatal burden of autism spectrum disorder are high, according to a review.

Augmenting medication for opioid use disorder (MOUD) with smartphone app-based contingency management (CM) is beneficial.

An expert panel has developed a hospital care plan for Parkinson disease to avoid preventable harm among patients.